Atlanta Braves Release Official Statement on Jurickson Profar’s Status
The Atlanta Braves have made a formal announcement regarding Jurickson Profar’s 162-game suspension due to a second violation of Major League Baseball’s (MLB) drug policy. The statement cleared up the team’s stance on the situation while affirming their continued support for MLB’s Drug Prevention and Treatment Program.
Braves Release Statement on Jurickson Profar
In their release, the Braves expressed their disappointment in Profar’s positive test for a performance-enhancing substance. They reiterated that their players receive ongoing education about the program and the serious implications of any violations. The team remains committed to promoting a drug-free environment.
Details of the Suspension
The suspension officially begins on March 6, 2026, as announced by the Office of the Commissioner of Baseball. Jurickson Profar tested positive for Exogenous Testosterone and its metabolites, leading to this severe penalty. This is his second positive test, which resulted in the lengthy suspension.
- Player: Jurickson Profar
- Team: Atlanta Braves
- Type of Suspension: 162 games without pay
- Effective Date: March 6, 2026
- Substance: Exogenous Testosterone
- Previous Suspension: 80 games for a prior PED test during the 2025 season
With this new suspension, the Braves will also avoid paying his 2026 salary and will not incur any associated tax. Furthermore, Profar will be ineligible for participation in the postseason.
Major League Baseball supports strict enforcement of drug policies, underscoring the league’s commitment to fairness and integrity among its players. The Braves will continue to uphold these principles as they move forward.
